Fibroblast growth factor-2 stimulates endothelial nitric oxide synthase expression and inhibits apoptosis by a nitric

P R Murphy1, M Limoges, F Dodd

  • 1Departments of Physiology and Biophysics, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada B3H 4H7.

Endocrinology
|January 6, 2001
PubMed

Insights

Fibroblast growth factor-2 (FGF-2) prevents apoptosis in prolactin-deprived Nb2 lymphoma cells. FGF-2 increases nitric oxide (NO) production and upregulates antiapoptotic genes bcl-2 and bag-1, promoting cell survival.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Rat Nb2 T lymphoma cells express fibroblast growth factor-2 (FGF-2) and its receptor, suggesting autocrine/paracrine roles.
  • Nb2 cells express endothelial nitric oxide synthase (eNOS) and produce nitric oxide (NO), inhibiting apoptosis via a bcl-2-mediated pathway.
  • Previous studies indicated NO inhibits apoptosis in prolactin (PRL)-deprived cells independently of PRL.

Purpose of the Study:

  • To investigate the effects of PRL and FGF-2 on Nb2 cell survival and NO production.
  • To elucidate the molecular mechanisms underlying FGF-2's antiapoptotic effects in PRL-deprived Nb2 cells.

Main Methods:

  • Quantification of nonapoptotic cells using flow cytometry.
  • Measurement of bcl-2 and bag-1 mRNA levels via quantitative real-time PCR.
  • Analysis of eNOS mRNA and protein expression, and NO production.
  • Assessment of FGF-2's effects in the presence of a nitric oxide synthase (NOS) inhibitor.

Main Results:

  • FGF-2 significantly inhibited apoptosis in PRL-deprived Nb2 cells, maintaining high cell survival (>85%).
  • FGF-2 markedly increased bcl-2 and bag-1 mRNA levels, with rapid induction observed within 1 hour.
  • FGF-2 upregulated eNOS mRNA and protein expression, leading to increased NO production, which was essential for the observed antiapoptotic effects.

Conclusions:

  • FGF-2 exerts a potent antiapoptotic effect on PRL-deprived Nb2 cells.
  • This effect is mediated by FGF-2-induced stimulation of eNOS expression, increased NO generation, and subsequent upregulation of antiapoptotic genes bcl-2 and bag-1.
  • FGF-2 represents a potential therapeutic target for modulating lymphoma cell survival.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...